Skip to main content
SpringerLink
Log in

Gastrointestinal Motility Problems in Patients with Parkinson’s Disease

Effects of Antiparkinsonian Treatment and Guidelines for Management

  • Disease Management
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Gastrointestinal (GI) motility disorders are frequent in patients with Parkinson’s disease, manifesting mainly as dysphagia, disorders of gastric emptying and constipation. The most likely causes of these disorders are cerebral degeneration and degeneration of the my enteric plexus. Although the effect of antiparkinsonian medication is largely overestimated, it certainly has an influence and should be adapted accordingly in patients with GI motility disorders. In particular, anti-cholinergic drugs should be avoided, and anamnesis, clinical examination and, if necessary, diagnostic tests performed.

Domperidone, a peripheral dopamine antagonist, is the drug of choice for motility disorders of the upper GI tract, although cisapride is an alternative. In the lower GI tract, conservative therapeutic options should be used in the first instance. The administration of cisapride leads to a marked temporary improvement in symptoms in lower GI disorders, while rare forms of anism (involuntary dystonic contraction of the anal sphincter) may be treated with botulinum toxin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones, 1817

    Google Scholar 

  2. Caplan LH, Jacobson HG, Rubinstein BM, et al. Megacolon and volvulus in Parkinson’s disease. Radiology 1965; 85: 73–8

    PubMed  CAS  Google Scholar 

  3. Eadie MJ, Tyrer JH. Alimentary disorders in parkinsonism. Australas Ann Med 1965; 14: 13–22

    PubMed  CAS  Google Scholar 

  4. Edwards L, Quigley EMM, Hofman R, et al. Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord 1993; 8: 83–6

    Article  PubMed  CAS  Google Scholar 

  5. Edwards LL, Quigley EMM, Harned RK, et al. Characterization of swallowing and defecation in Parkinson’s disease. Am J Gastroenterol 1994; 89: 15–25

    PubMed  CAS  Google Scholar 

  6. Korczyn AD. Autonomic nervous system disturbances in Parkinson’s disease. Adv Neurol 1990; 53: 463–8

    PubMed  CAS  Google Scholar 

  7. Den Hartog Jager WA. Sphingomyelin in Lewy inclusion bodies in Parkinson’s disease. Arch Neurol 1969; 21: 615–9

    Article  CAS  Google Scholar 

  8. Forno LS. The Lewy body in Parkinson’s disease. Adv Neurol 1986; 45: 35–43

    Google Scholar 

  9. Kupsky WJ, Grimes MM, Sweeting J, et al. Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 1987; 37: 1253–5

    Article  PubMed  CAS  Google Scholar 

  10. Ohama E, Ikuta E Parkinson’s disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol (Berl) 1976; 34: 311–9

    Article  CAS  Google Scholar 

  11. Qualman SJ, Haupt HM, Yang P, et al. Esophageal Lewy bodies associated with ganglion cell loss in achalasia: similarity to Parkinson’s disease. Gastroenterology 1984; 87: 848–56

    PubMed  CAS  Google Scholar 

  12. Wakabayashi K, Takahashi H, Ohama E, et al. Lewy bodies in the visceral autonomic nervous system in Parkinson’s disease. Adv Neurol 1993; 60: 609–12

    PubMed  CAS  Google Scholar 

  13. Edwards LL, Pfeiffer RF, Quigley EMM, et al. Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 1991; 6: 151–6

    Article  PubMed  CAS  Google Scholar 

  14. Klaue R. Parkinsonsche Krankheit (Paralysis agitans) und post-encephalitischer Parkinsonismus. Archiv fur Psychiatrie 1940; 111: 251–321

    Article  Google Scholar 

  15. Kuroiwa Y, Shimada Y, Toyokura Y. Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 1983; 33: 463–7

    Article  PubMed  CAS  Google Scholar 

  16. Oppenheim H. Kleine Beiträge zur Neuropathologie. J Psychol Neurol 1902; 1: 129–46

    Google Scholar 

  17. Koller WC. Handbook of Parkinson’s disease. New York: Marcel Dekker Inc., 1992

    Google Scholar 

  18. Bateson MC, Gibberd FB, Wilson RSE. Salivary symptoms in Parkinson disease. Arch Neurol 1973; 29: 274–5

    Article  PubMed  CAS  Google Scholar 

  19. Schwab RS, England AC. Parkinson’s disease. J Chronic Dis 1958; 8: 488–509

    Article  PubMed  CAS  Google Scholar 

  20. Palmai G, Blackwell B. The diurnal pattern of salivary flow in normal and depressed patients. Br J Psychiatry 1965; 111: 334–8

    Article  PubMed  CAS  Google Scholar 

  21. Parkes JD. Domperidone and Parkinson’s disease. Clin Neuro-pharmacol 1986; 9: 517–32

    CAS  Google Scholar 

  22. Bushmann M, Dobmeyer SM, Leeker L, et al. Swallowing abnormalities and their response to treatment in Parkinson’s disease. Neurology 1989; 39: 1309–14

    Article  PubMed  CAS  Google Scholar 

  23. Logemann JA, Blonsky ER, Boshes B. Dysphagia in parkinsonism. JAMA 1975; 231: 69–70

    Article  PubMed  CAS  Google Scholar 

  24. Nowack WJ, Hatelid JM, Sohn RS. Dysphagia in parkinsonism [letter]. Arch Neurol 1977; 34: 320

    Article  PubMed  CAS  Google Scholar 

  25. Fischer RA, Ellison GW, Thayer WR, et al. Esophageal motility in neuromuscular disorders. Ann Intern Med 1965; 63: 229–48

    PubMed  CAS  Google Scholar 

  26. Calne DB, Shaw DG, Spiers ASD, et al. Swallowing in parkinsonism. Br J Radiol 1970; 43: 456–7

    Article  PubMed  CAS  Google Scholar 

  27. Eadie MJ, Tyrer JH. Radiological abnormalities of the upper part of the alimentary tract in parkinsonism. Australas Ann Med 1965; 14: 23–7

    PubMed  CAS  Google Scholar 

  28. Palmer ED. Dysphagia in parkinsonism [editorial]. JAMA 1974; 229: 1349

    Article  PubMed  CAS  Google Scholar 

  29. Cotzias GC, Papavasiliou PS, Gellene R. Modification of parkinsonism - chronic treatment with L-dopa. N Engl J Med 1969; 280: 337–45

    Article  PubMed  CAS  Google Scholar 

  30. Bramble MG, Cunliffe J, Dellipiani AW. Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1978; 41: 709–12

    Article  PubMed  CAS  Google Scholar 

  31. Kempster PA, Lees AJ, Crichton P, et al. Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson’s disease and its treatment with apomorphine. Mov Disord 1989; 4: 47–52

    Article  PubMed  CAS  Google Scholar 

  32. Lieberman AN, Horowitz L, Redmond P, et al. Dysphagia in Parkinson’s disease. Am J Gastroenterol 1980; 74: 157–60

    PubMed  CAS  Google Scholar 

  33. Gibberd FB, Gleeson JA, Gossage AAR, et al. Oesophageal dilatation in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1974; 37: 938–40

    Article  PubMed  CAS  Google Scholar 

  34. Jost WH, Schimrigk K. Cisapride treatment of constipation in Parkinson’s disease. Mov Disord 1993; 8: 339–43

    Article  PubMed  CAS  Google Scholar 

  35. Kaneoke Y, Koike Y, Sakurai N, et al. Gastrointestinal dysfunction in Parkinson’s disease detected by electrogastroenter-ography. J Auton Nerv Syst 1995; 50: 275–81

    Article  PubMed  CAS  Google Scholar 

  36. Djaldetti R, Baron J, Ziv I, et al. Gastric emptying in Parkinson’s disease: patients with and without response fluctuations. Neurology 1996; 46: 1051–4

    Article  PubMed  CAS  Google Scholar 

  37. Kurlan R, Rubin AJ, Miller C, et al. Continuous intraduodenal infusion of levodopa for resistant on-off fluctuations in parkinsonism [abstract]. Ann Neurol 1985; 18: 139

    Google Scholar 

  38. Champion MC. Domperidone. Gen Pharmacol 1988; 19: 499–505

    Article  PubMed  CAS  Google Scholar 

  39. Mearrick PT, Wade DN, Birkett DJ, et al. Metoclopramide, gastric emptying and L-dopa absorption. Aust N Z J Med 1974; 4: 144–8

    Article  PubMed  CAS  Google Scholar 

  40. Wade DN, Mearrick PT, Birkett DT, et al. Variability of L-dopa absorption in man. Aust N Z J Med 1974; 4: 138–43

    Article  PubMed  CAS  Google Scholar 

  41. Rivera-Calimlim L, Dujovne CA, Morgan JP, et al. L-dopa treatment failure: explanation and correction. BMJ 1970; 4: 93–4

    Article  PubMed  CAS  Google Scholar 

  42. Indo T, Ando K. Metoclopramide-induced parkinsonism. Arch Neurol 1982; 39: 494–6

    Article  PubMed  CAS  Google Scholar 

  43. Paulseth JE, Jensen JJJ, Klawans HL. Domperidone therapy in patients with Parkinson’s disease with levodopa-carbidopa-related gastrointestinal complaints. Ann Neurol 1984; 16: 127–8

    Google Scholar 

  44. Eadie MJ. Gastric secretion in parkinsonism. Australas Ann Med 1963; 12: 346–50

    PubMed  CAS  Google Scholar 

  45. Bingham JR, Ingelfinger FJ, Smithwick RH. The effects of sympathectomy on the motility of the human gastrointestinal and biliary tracts. Gastroenterology 1950; 15: 6–17

    PubMed  CAS  Google Scholar 

  46. Lewitan A, Nathanson L, Slade WR. Megacolon and dilatation of the small bowel in parkinsonism. Gastroenterology 1951; 17: 367–74

    PubMed  CAS  Google Scholar 

  47. Calne DB, Brennan J, Spiers ASD, et al. Hypotension caused by L-dopa. BMJ 1970; I: 474–5

    Article  Google Scholar 

  48. Jost WH, Schimrigk K. Constipation in Parkinson’s disease. Klin Wochenschr 1991; 69: 906–9

    Article  PubMed  CAS  Google Scholar 

  49. Mesec A, Sega S, Kiauta T. The influence of the type, duration, severity and levodopa treatment of Parkinson’s disease on cardiovascular autonomic responses. Clin Auton Res 1993; 3: 339–44

    Article  PubMed  CAS  Google Scholar 

  50. Turkka JT, Juujärvi KK, Lapinlampi TO, et al. Serum noradren-aline response to standing up in patients with Parkinson’s disease. Eur Neurol 1986; 25: 355–61

    Article  PubMed  CAS  Google Scholar 

  51. Wang SJ, Fuh JL, Shan DE, et al. Sympathetic skin response and R-R interval variation in Parkinson’s disease. Mov Disord 1993; 8: 151–7

    Article  PubMed  CAS  Google Scholar 

  52. Pallis CA. Parkinsonism: natural history and clinical features. BMJ 1971; 3: 683–90

    Article  PubMed  CAS  Google Scholar 

  53. Singer C, Weiner WJ, Sanchez-Ramos JR. Autonomic dysfunction in men with Parkinson’s disease. Eur Neurol 1992; 32: 134–40

    Article  PubMed  CAS  Google Scholar 

  54. Kuroiwa Y, Wada T, Tohgi H. Measurement of blood pressure and heart-rate variation while resting supine and standing for the evaluation of autonomic dysfunction. J Neurol 1987; 235: 65–8

    Article  PubMed  CAS  Google Scholar 

  55. Porter RW, Bors E. Neurogenic bladder in parkinsonism: effect of thalamotomy. J Neurosurg 1971; 34: 27–32

    Article  PubMed  CAS  Google Scholar 

  56. Jost WH, Schimrigk K. Bestimmung der Kolontransitzeit beim Parkinson - Syndrom. Aktuelle Neurol 1992; 19: 52–3

    Article  Google Scholar 

  57. Neundörfer B. Risiken und Nebenwirkungen der medikamentösen Therapie. Nervenheilkunde 1992; 11: 63–7

    Google Scholar 

  58. Siegmund H. Anatomisch nachgewiesene Folgen von Tonus-und Motilitätsstörungen des Verdauungskanals bei Enzepha-litikern, die mit Atropin behandelt wurden. MMW Munch Med Wochenschr 1935; 82: 453–4

    Google Scholar 

  59. Jost WH, Jung G, Schimrigk K. Colonic transit in non-idiopathic Parkinson’s syndrome. Eur Neurol 1994; 34: 329–31

    Article  PubMed  CAS  Google Scholar 

  60. Herrn F, Jordan E, Jost WH, et al. Colontransitzeit bei neuromus-kulären Erkrankungen vor und nach Colonreflexmassagen [abstract]. Med Klin 1995; 90: 199

    Google Scholar 

  61. Den Hartog Jager WA, Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous system in idio-pathic paralysis agitans. J Neurol Neurosurg Psychiatry 1960; 23: 283–90

    Article  PubMed  CAS  Google Scholar 

  62. Eadie MJ. The pathology of certain medullary nuclei in parkinsonism. Brain 1963; 86: 781–92

    Article  PubMed  CAS  Google Scholar 

  63. Oyanagi K, Wakabayashi K, Ohama E, et al. Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson’s disease. Acta Neuropathol 1990; 80: 558–9

    Article  PubMed  CAS  Google Scholar 

  64. Singaram C, Ashraf W, Quigley EMM, et al. Enteric nervous system (ENS) dopamine depletion in Parkinson’s disease (PD) [abstract]. Mov Disord 1994; 9 Suppl. 1: 100

    Google Scholar 

  65. Wakabayashi K, Takahashi H, Takeda S, et al. Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 1988; 76: 217–21

    Article  PubMed  CAS  Google Scholar 

  66. Mathers SE, Kempster PA, Law PJ, et al. Anal sphincter dysfunction in Parkinson’s disease. Arch Neurol 1989; 46: 1061–4

    Article  PubMed  CAS  Google Scholar 

  67. Ashraf W, Pfeiffer RF, Quigley EMM. Anorectal manometry in the assessment of anorectal function in Parkinson’s disease: a comparison with chronic idiopathic constipation. Mov Disord 1994; 9: 655–63

    Article  PubMed  CAS  Google Scholar 

  68. Jost WH, Raulf F, Schimrigk K. Anismus: Definition, Patho-physiologie, Diagnose und Therapie. Kontinenz 1994; 3: 211–5

    Google Scholar 

  69. Mathers SE, Kempster PA, Swash M, et al. Constipation and paradoxical puborectalis contraction in anismus and Parkinson’s disease: a dystonic phenomenon?. J Neurol Neurosurg Psychiatry 1988; 51: 1503–7

    Article  PubMed  CAS  Google Scholar 

  70. Reboa G, Arnulfo G, Frascio M, et al. Colon motility and colo-anal reflexes in chronic idiopathic constipation. Eur J Clin Pharmacol 1984; 26: 745–8

    Article  PubMed  CAS  Google Scholar 

  71. Djaldetti R, Koren M, Achiron A, et al. Effect of cisapride on response fluctuations in Parkinson’s disease. Mov Disord 1995; 10: 81–4

    Article  PubMed  CAS  Google Scholar 

  72. Neira WD, Sanchez V, Mena MA, et al. The effects of cisapride on plasma L-dopa levels and response in Parkinson’s disease. Mov Disord 1995; 10: 66–70

    Article  PubMed  CAS  Google Scholar 

  73. Jost WH, Schimrigk K. Long-term results with cisapride in Parkinson’s disease. Mov Disord. In press

  74. Jost WH, Schimrigk K. Elektromyogramm des M. sphincter ani externus beim idiopathischen Parkinson Syndrom. Aktuelle Neurol 1996; 23: 167–70

    Article  Google Scholar 

  75. Wenning GK, Quinn N. Multisytematrophie. Aktuelle Neurol 1994; 21: 120–6

    Article  Google Scholar 

  76. Jost WH. Neurologie des Beckenbodens. London: Chapman & Hall, 1997

    Google Scholar 

  77. Lewy FH. Zur pathologischen Anatomie der Paralysis agitans. Dtsch Z Nervenheilkd 1913; 50: 50–5

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, German Diagnostic Clinic, Aukammallee 33, 65191, Wiesbaden, Germany

    Wolfgang H. Jost

Authors
  1. Wolfgang H. Jost
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jost, W.H. Gastrointestinal Motility Problems in Patients with Parkinson’s Disease. Drugs & Aging 10, 249–258 (1997). https://doi.org/10.2165/00002512-199710040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199710040-00002

Keywords

Search

Navigation